N-linked macrocyclic 4-(pyrazol-5-yl)-indole derivatives as MCL-1 inhibitors
The present invention relates to agents useful in the treatment and/or prophylaxis of subjects, pharmaceutical compositions comprising such compounds, and their use as MCL-1 inhibitors useful in the treatment of diseases such as cancer. 本发明涉及可用于受试者的治疗和/或预防的药剂,包含此类化合物的药物组合物,以及它们作为可用于治疗疾病诸如癌症的MCL-1抑制剂...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to agents useful in the treatment and/or prophylaxis of subjects, pharmaceutical compositions comprising such compounds, and their use as MCL-1 inhibitors useful in the treatment of diseases such as cancer.
本发明涉及可用于受试者的治疗和/或预防的药剂,包含此类化合物的药物组合物,以及它们作为可用于治疗疾病诸如癌症的MCL-1抑制剂的用途。 |
---|